NCT03798626 2026-04-01Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal CancersNovartisPhase 1 Completed167 enrolled
NCT03170960 2025-08-17Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsExelixisPhase 1 Active not recruiting914 enrolled
NCT04868773 2025-04-16Study of Cabozantinib Plus TAS102 in mCRC as Salvage TherapyUniversity of California, IrvinePhase 1 Active not recruiting12 enrolled